Literature DB >> 34308563

Coexistence of Takayasu arteritis and chronic myeloid leukemia: Coincidental or paraneoplastic phenomenon?

Tuba Yuce Inel1, Aytac Gulcu2, Ali Karakas1, Elcin Erdogan Yucel3, Fatos Onen1.   

Abstract

Vasculitis may rarely be seen in the course of myeloproliferative neoplasms (MPN). In vasculitis associated with hematological diseases, mostly small- and medium-vessel involvement is expected, aortitis is very rare. It is not exactly known whether large-vessel vasculitis associated with MPN is a paraneoplastic phenomenon or coincidental. We aimed to present an uncommon case diagnosed with chronic myeloid leukemia and Takayasu arteritis concurrently.
© 2021 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Takayasu arteritis; chronic myeloid leukemia; large-vessel vasculitis; myeloproliferative neoplasms; paraneoplastic phenomenon

Mesh:

Substances:

Year:  2021        PMID: 34308563     DOI: 10.1111/1756-185X.14186

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  3 in total

Review 1.  Diffused coronary involvement in Takayasu arteritis with concomitant malignancy.

Authors:  Inbar Nardi-Agmon; Ashraf Hamdan; Alon Eisen; Katia Orvin; Avital Porter; Hana Vaknin-Assa; Gilad Itchaki; Yair Molad; Ran Kornowski; Osnat Itzhaki Ben Zadok
Journal:  Clin Rheumatol       Date:  2021-11-27       Impact factor: 2.980

2.  Cancer-associated vasculitides: a single-centre case series.

Authors:  Hyunsue Do; Jung Yoon Pyo; Sung Soo Ahn; Jason Jungsik Song; Yong-Beom Park; Sang-Won Lee
Journal:  Clin Rheumatol       Date:  2022-09-09       Impact factor: 3.650

Review 3.  Spectrum of Large- and Medium-Vessel Vasculitis in Adults: Neoplastic, Infectious, Drug-Induced, Autoinflammatory, and Primary Immunodeficiency Diseases.

Authors:  Fabian Lötscher; Roxana Pop; Pascal Seitz; Mike Recher; Luca Seitz
Journal:  Curr Rheumatol Rep       Date:  2022-08-03       Impact factor: 4.686

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.